These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 35887191)

  • 1. Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers.
    Addanki S; Meas S; Sarli VN; Singh B; Lucci A
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells and circulating tumor DNA in breast cancer diagnosis and monitoring.
    Alemzadeh E; Allahqoli L; Dehghan H; Mazidimoradi A; Ghasempour A; Salehiniya H
    Oncol Res; 2023; 31(5):667-675. PubMed ID: 37547763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liquid biopsy in breast cancer: A comprehensive review.
    Alimirzaie S; Bagherzadeh M; Akbari MR
    Clin Genet; 2019 Jun; 95(6):643-660. PubMed ID: 30671931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liquid biopsy: current technology and clinical applications.
    Nikanjam M; Kato S; Kurzrock R
    J Hematol Oncol; 2022 Sep; 15(1):131. PubMed ID: 36096847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in liquid biopsy using circulating tumor cells and circulating cell-free tumor DNA for detection and monitoring of breast cancer.
    Zhang X; Ju S; Wang X; Cong H
    Clin Exp Med; 2019 Aug; 19(3):271-279. PubMed ID: 31190187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serial monitoring of genomic alterations in circulating tumor cells of ER-positive/HER2-negative advanced breast cancer: feasibility of precision oncology biomarker detection.
    Cani AK; Dolce EM; Darga EP; Hu K; Liu CJ; Pierce J; Bradbury K; Kilgour E; Aung K; Schiavon G; Carroll D; Carr TH; Klinowska T; Lindemann J; Marshall G; Rowlands V; Harrington EA; Barrett JC; Sathiyayogan N; Morrow C; Sero V; Armstrong AC; Baird R; Hamilton E; Im SA; Jhaveri K; Patel MR; Dive C; Tomlins SA; Udager AM; Hayes DF; Paoletti C
    Mol Oncol; 2022 May; 16(10):1969-1985. PubMed ID: 34866317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Profiling of Liquid Biopsies for Precision Oncology.
    Gonzalez-Kozlova EE
    Adv Exp Med Biol; 2022; 1361():235-247. PubMed ID: 35230692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liquid Biopsy in Breast Cancer: A Focused Review.
    Tay TKY; Tan PH
    Arch Pathol Lab Med; 2021 Jun; 145(6):678-686. PubMed ID: 32045277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of circulating tumor DNA in breast cancer.
    Zhao Y; Sheng M; Zheng L; Xiong D; Yang K; Luo Y
    Breast J; 2020 Sep; 26(9):1797-1800. PubMed ID: 32052544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?
    Asante DB; Calapre L; Ziman M; Meniawy TM; Gray ES
    Cancer Lett; 2020 Jan; 468():59-71. PubMed ID: 31610267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Tumor DNA Is a Variant of Liquid Biopsy with Predictive and Prognostic Clinical Value in Breast Cancer Patients.
    Zavarykina TM; Lomskova PK; Pronina IV; Khokhlova SV; Stenina MB; Sukhikh GT
    Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid Biopsy as a Tool for the Diagnosis, Treatment, and Monitoring of Breast Cancer.
    Freitas AJA; Causin RL; Varuzza MB; Calfa S; Hidalgo Filho CMT; Komoto TT; Souza CP; Marques MMC
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid Biopsy in the Clinical Management of Cancers.
    Ho HY; Chung KK; Kan CM; Wong SC
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating Tumor DNA in the Management of Early-Stage Breast Cancer.
    Vlataki K; Antonouli S; Kalyvioti C; Lampri E; Kamina S; Mauri D; Harissis HV; Magklara A
    Cells; 2023 Jun; 12(12):. PubMed ID: 37371043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
    Moldogazieva NT; Zavadskiy SP; Terentiev AA
    Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond blood: Advancing the frontiers of liquid biopsy in oncology and personalized medicine.
    Bao Y; Zhang D; Guo H; Ma W
    Cancer Sci; 2024 Apr; 115(4):1060-1072. PubMed ID: 38308498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid biopsies: Potential and challenges.
    Heidrich I; Ačkar L; Mossahebi Mohammadi P; Pantel K
    Int J Cancer; 2021 Feb; 148(3):528-545. PubMed ID: 32683679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of Liquid Biopsies for Breast Cancer Screening, Diagnosis, and Response to Treatment.
    Eigeliene N; Saarenheimo J; Jekunen A
    Oncology; 2019; 96(3):115-124. PubMed ID: 30654364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of liquid biopsy in precision medicine: opportunities and challenges.
    Wang J; Chang S; Li G; Sun Y
    Front Med; 2017 Dec; 11(4):522-527. PubMed ID: 28744793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid Biopsy in Breast Cancer: Circulating Tumor Cells and Circulating Tumor DNA.
    Yoo TK
    Adv Exp Med Biol; 2021; 1187():337-361. PubMed ID: 33983587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.